Heart valve disease affects about 2.5% of Americans and is more common in older adults. Mitral valve prolapse can be harmless but may lead to significant mitral regurgitation in some people. Aortic ...
In the RESHAPE-HF2 trial, 505 patients with systolic HF (left ventricular ejection fraction 20-50% and New York Heart Association [NYHA] class II-IV HF symptoms) and moderate to severe functional MR ...
The U.S. Food and Drug Administration has approved on April 2 the Abbott TriClip™, a transcatheter edge-to-edge repair (TEER) system specifically designed for the treatment of tricuspid regurgitation ...